Genetic origin and imprinting in hydatidiform moles: Comparison between DNA polymorphism analysis and immunoreactivity of p57 KIP2

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 50, Issue 5, 2005, Pages 307-312

  Kihara, Maki ^a   Matsui, Hideo ^b   Seki, Katsuyoshi ^b   Nagai, Yuichiro ^b   Wake, Norio ^b   Sekiya, Souei ^b  

^a CHIBA UNIVERSITY   (Japan)

^b NONE

Author keywords

DNA; Hydatidiform mole; p57 KIP2; Polymorphism (genetics)

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; P57KIP2; PROTEIN P57; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOTROPHOBLAST; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC CORRELATION; GENOME IMPRINTING; GESTATIONAL AGE; HUMAN; HYDATIDIFORM MOLE; IMMUNOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA; FEMALE; GENOMIC IMPRINTING; HUMANS; HYDATIDIFORM MOLE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; PREGNANCY; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 18844378095     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Szulman AE, Surti U: The syndromes of hydatidiform mole: II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 1978;132:20-27
2. Genest DR, Berkowitz RS, Fisher RA, et al: Gestational trophoblastic disease. In World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Edited by FA Tavassoli, P Devilee. Lyon, IARC Press, 2003
3. Mosher R, Goldstein DP, Berkowitz R, et al: Complete hydatidiform mole: Comparison of clinicopathologic features, current and past. J Reprod Med 1998;43:21-27
4. Fox H: Differential diagnosis of hydatidiform moles. Gen Diagn Pathol 1997;143:117-125
5. Kajii T, Ohama K: Androgenetic origin of hydatidiform mole. Nature 1977;268:633-634
6. Matsuda T, Wake N: Genetics and molecular markers in gestational trophoblastic disease with special reference to their clinical application. Best Pract Res Clin Obstet Gynaecol 2003;17:827-836
7. Genest DR: Partial hydatidiform mole: Clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol 2001;20:315-322
8. Ishii J, Iitsuka Y, Takano H, et al: Genetic differentiation of complete hydatidiform moles coexisting with normal fetuses by short tandem repeat-derived deoxyribonucleic acid polymorphism analysis. Am J Obstet Gynecol 1998;179:628-634
9. Shahib N, Martaadisoebrata D, Kondo H, et al: Genetic origin of malignant trophoblastic neoplasms analyzed by sequence tag site polymorphic markers. Gynecol Oncol 2001;81:247-253
10. Saxena A, Frank D, Panichkul P, et al: The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole. Placenta 2003;24:835-842
11. Chilosi M, Piazzola E, Lestani M, et al: Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 1998;78:269-276
12. Castrillon DH, Sun D, Weremowicz S, et al: Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol 2001;25:1225-1230
13. KIP2 to assist molar classification. J Reprod Med 2002;47:342-346
14. Fisher RA, Hodges MD, Rees HC, et al: The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet 2002;11:3267-3272
15. Fukunaga M: Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. Hum Pathol 2002;33:1188-1192
16. Jun SY, Ro JY, Kim KR: p57kip2 Is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology 2003;43:17-25
17. Crisp H, Burton JL, Stewart R, et al: Refining the diagnosis of hydatidiform mole: Image ploidy analysis and p57KIP2 immunohistochemistry. Histopathology 2003;43:363-373
18. Paradinas FJ, Browne P, Fisher RA, et al: A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology 1996;28:101-110
19. Conran RM, Hitchcock CL, Popek EJ, et al: Diagnostic considerations in molar gestations. Hum Pathol 1993;24:41-48
20. Keep D, Zaragoza MV, Hassold T, et al: Very early complete hydatidiform mole. Hum Pathol 1996 ;27:708-713
21. Miller D, Jackson R, Ehlen T, et al: Complete hydatidiform mole coexistent with a twin live fetus: Clinical course of four cases with complete cytogenetic analysis. Gynecol Oncol 1993;50:119-123
22. Matsui H, Sekiya S, Hando T, et al: Hydatidiform mole coexistent with a twin live fetus: A national collaborative study in Japan. Hum Reprod 2000;15:608-611
23. Lawler SD, Fisher RA, Dent J: A prospective genetic study of complete and partial hydatidiform moles. Am J Obstet Gynecol 1991;164:1270-1277
24. Vassilakos P, Riotton G, Kajii T: Hydatidiform mole: Two entities: A morphologic and cytogenetic study with some clinical consideration. Am J Obstet Gynecol 1977;127:167-170
25. Fisher RA, Newlands ES: Gestational trophoblastic disease: Molecular and genetic studies. J Reprod Med 1998;43:87-97
26. Lage JM, Berkowitz RS, Rice LW, et al: Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Obstet Gynecol 1991;77:111-115